Imaging Forward campaign highlights technological advances in medical imaging and impact on patient care.
The Medical Imaging and Technology Alliance (MITA) announced a new campaign this week aimed at highlighting groundbreaking innovation in medical imaging technologies and the impact of these advances on patient care and healthcare delivery.
Imaging has transformed patient care, and thus the practice of medicine, by improving diagnosis and treatment and avoiding unnecessary procedures, which in turn lowers costs, Gail Rodriguez, executive director of MITA, said in a release. With manufacturers investing in research and development, exploratory surgery is almost obsolete. And patients and physicians are equally benefitting from advanced imaging technologies that save lives and reduce long-term healthcare spending.
Using Twitter, Facebook, and a microvideo series (including Vine), MITA’s campaign Imaging Forward, will highlight the progress made in medical imaging through the past 20 years, and introduce the imaging technologies we can expect in the future.
“Medical imaging innovation has helped transform modern healthcare. Imaging exams reduce invasive surgeries, unnecessary hospital admissions, length of hospital stays and are directly linked to greater life expectancy. Every day, worldwide, medical imaging leads to earlier diagnoses, better, more targeted treatment and lives saved that, in the past, may have been lost,” Paul H. Ellenbogen, MD, FACR, chair of the American College of Radiology Board of Chancellors, said in a release.
Despite the significant benefits of medical imaging innovation, Congress and CMS have cut Medicare imaging reimbursements multiple times since 2006. In addition, under the 2.3 percent medical device excise tax imposed by the Affordable Care Act, manufacturers are required to pay more than $2 billion per year in tax payments, which poses a serious threat to manufacturers’ ability to invest in innovation, and drive job creation and economic growth, according to MITA.
FDA Grants Expanded 510(k) Clearance for Xenoview 3T MRI Chest Coil in GE HealthCare MRI Platforms
November 21st 2024Utilized in conjunction with hyperpolarized Xenon-129 for the assessment of lung ventilation, the chest coil can now be employed in the Signa Premier and Discovery MR750 3T MRI systems.
FDA Clears AI-Powered Ultrasound Software for Cardiac Amyloidosis Detection
November 20th 2024The AI-enabled EchoGo® Amyloidosis software for echocardiography has reportedly demonstrated an 84.5 percent sensitivity rate for diagnosing cardiac amyloidosis in heart failure patients 65 years of age and older.
New Study Examines Agreement Between Radiologists and Referring Clinicians on Follow-Up Imaging
November 18th 2024Agreement on follow-up imaging was 41 percent more likely with recommendations by thoracic radiologists and 36 percent less likely on recommendations for follow-up nuclear imaging, according to new research.